GALECTIN THERAPEUTICS INC
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Operating income | -$20.1 | -$42.4 | -$38.1 | -$38.4 | -$30.2 |
| Net income | -$30.8 | -$47.0 | -$41.1 | -$38.8 | -$30.5 |
Shares outstanding 100.8M
Annual filing data through FY ended December 31, 2025; float as of September 9, 2026.